Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration
Status: | Terminated |
---|---|
Conditions: | Skin Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 15 - Any |
Updated: | 2/23/2019 |
Start Date: | November 2014 |
End Date: | June 4, 2018 |
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)
The purpose of this study is to allow the collection of tissue from subjects to be used in
future research studies by scientists and to isolate tumor fighting cells for the future
treatment of Melanoma.
future research studies by scientists and to isolate tumor fighting cells for the future
treatment of Melanoma.
Inclusion Criteria:
1. Patients must have metastatic melanoma with a resectable metastasis who are undergoing
resection for palliation, therapeutic or curative purpose.
2. Patients must be > 15 years of age and must have metastatic melanoma.
3. Patients must meet standard pre-operative requirements as determined by the surgeon to
be candidates for surgery.
4. Patients must be able to understand and sign the Informed Consent document.
5. Patients must be able to complete the supplemental data form
Exclusion Criteria:
1. women who are pregnant or breastfeeding
2. inability to give consent
We found this trial at
1
site
2200 Santa Monica Blvd
Santa Monica, California 90404
Santa Monica, California 90404
(310) 582-7438
Principal Investigator: Mark B. Faries, M.D.
Phone: 310-582-7456
Click here to add this to my saved trials